Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic.
Where this comes from
- Record sourced from PubMed, PMID 33320215.
- Also identified by DOI 10.1001/jama.2020.22154 and PMC identifier PMC7428767.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This study examined outpatient buprenorphine dispensing patterns in Texas before vs after the Drug Enforcement Administration temporarily relaxed outpatient buprenorphine prescribing regulations in March 2020 in response to the COVID-19 pandemic.